While the coronavirus pandemic has shaken many industries to their core, the European medical cannabis industry continues to flourish. A number of recent developments in Germany show that the demand for medicinal cannabis is growing. But the German medical cannabis industry is also facing a number of challenges, including an unmet patient demand and a lack of regulatory guidelines for producers.

LABIOTECH.eu has caught up with Peter Homberg, Partner and Head of the German Life Sciences Practice and the European Cannabis Group, to discuss the latest news from the German medical cannabis sector and talk about recent developments regarding the pricing, cultivation, and import of medicinal cannabis in Germany.

Read the full interview here.